Breaking News Instant updates and real-time market news.

PG

Procter & Gamble

$91.22

0.22 (0.24%)

05:49
03/21/17
03/21
05:49
03/21/17
05:49

Procter & Gamble initiated with a Neutral at JPMorgan

JPMorgan analyst Andrea Teixeira started Procter & Gamble with a Neutral rating and $98 price target.

PG Procter & Gamble
$91.22

0.22 (0.24%)

03/06/17
03/06/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. MetLife (MET) downgraded to Neutral from Buy at BofA/Merrill with analyst Seth Weiss saying shares are now trading above the level of the disappointing fourth quarter earnings report and prefers Prudential (PRU) given it benefits more from improving interest rates and easing regulations. 2. Procter & Gamble (PG) downgraded to Neutral from Buy at B. Riley with analyst Linda Bolton Weiser saying that while the stock is up 11% from the December low, the company's fundamentals have weakened. The analyst cut her price target for the shares to $91 from $106. 3. GoPro (GPRO) downgraded to Sell from Neutral at Goldman with analyst Simona Jankowski saying the company faces "significant challenges" amid camera market saturation, product rollout issues in the holiday season, and a disappointing entry into the drone market. The analyst sees risk to consensus estimates and views the stock as overvalued. 4. Hawaiian Electric (HE) downgraded to Underperform from In Line at Evercore ISI with analyst Greg Gordon saying he believes the risk/return for shares is skewed to the downside and estimates a "significantly lower total return" compared to other utilities he covers. He maintains a $31 price target on Hawaiian Electric shares. 5. Akorn (AKRX) downgraded to Hold from Buy at Deutsche Bank with analyst Gregg Gilbert saying the risk/reward is more balanced following the recent rally in the shares. Upside from current levels will have more to do with the "hard-to-call dynamics of new product approvals vs. base business erosion," Gilbert tells investors in a research note. He cut his price target for the shares to $24 from $28. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/06/17
RILY
03/06/17
DOWNGRADE
Target $91
RILY
Neutral
Procter & Gamble downgraded to Neutral from Buy at B. Riley
B. Riley analyst Linda Bolton Weiser downgraded Procter & Gamble to Neutral saying that while the stock is up 11% from the December low, the company's fundamentals have weakened. The analyst cut her price target for the shares to $91 from $106.
02/27/17
RBCM
02/27/17
NO CHANGE
RBCM
Edgewell Personal Care should be bought at current levels, says RBC Capital
RBC Capital analyst Nik Modi says that Edgewell's stock has underperformed the market by about 9% since Procter & Gamble (PG) announced that it would lower the prices of its U.S. blades/razor business as of April 1. The analyst says that the market may be overestimating the ultimate impact of the price cuts on Edgewell. Modi recommends buying Edgewell at current levels and keeps a $105 price target on the name.
02/15/17
DBAB
02/15/17
NO CHANGE
Target $90
DBAB
Hold
Deutsche expects whitepaper from Trian on Procter & Gamble
Deutsche Bank analyst Bill Schmitz expects Procter & Gamble's newest activist investor, Nelson Peltz's Train, to issue a whitepaper detailing the investment case in the name. The whitepaper will likely include the strategic and financial benefits of splitting up the company, exploration of M&A options for the businesses, and cost savings opportunities, Schmitz tells investors in a research note. He believes the best way for P&G to "prove its competence is to grow the business, not rip out more costs or introduce further financial engineering." After Bill Ackman's original involvement in July 2012, the company has largely been its own activist, the analyst contends. Schmitz keeps a Hold rating on Procter & Gamble with a $90 price target.

TODAY'S FREE FLY STORIES

11:30
05/22/17
05/22
11:30
05/22/17
11:30
General news
U.S. VIX equity volatility sank 4% to 11.56 »

U.S. VIX equity…

MRK

Merck

$64.16

0.375 (0.59%)

11:25
05/22/17
05/22
11:25
05/22/17
11:25
Hot Stocks
Merck says Phase 2 study results warrant continued evaluation of MK-7264 »

Merck announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 27

    May

  • 31

    May

  • 02

    Jun

  • 05

    Jun

  • 09

    Jun

  • 14

    Jun

LC

LendingClub

$5.92

0.26 (4.59%)

, ONDK

On Deck Capital

$3.71

0.32 (9.44%)

11:23
05/22/17
05/22
11:23
05/22/17
11:23
Periodicals
Online lendeers attract bond buyers, WSJ says »

According to…

LC

LendingClub

$5.92

0.26 (4.59%)

ONDK

On Deck Capital

$3.71

0.32 (9.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 27

    Jun

  • 28

    Jun

  • 29

    Jun

MGM

MGM Resorts

$31.66

0.41 (1.31%)

11:20
05/22/17
05/22
11:20
05/22/17
11:20
Options
Notable option blocks in MGM »

Notable option blocks in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

11:17
05/22/17
05/22
11:17
05/22/17
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

11:16
05/22/17
05/22
11:16
05/22/17
11:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTBC

Medical Transcription Billing

$1.90

0.02 (1.06%)

11:15
05/22/17
05/22
11:15
05/22/17
11:15
Hot Stocks
MTBC jumps after announcing releases of app for smartphones »

Earlier today, MTBC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:15
05/22/17
05/22
11:15
05/22/17
11:15
General news
Breaking General news story  »

3-Month Bill Auction to…

11:15
05/22/17
05/22
11:15
05/22/17
11:15
General news
Breaking General news story  »

6-Month Bill Auction to…

XOM

Exxon Mobil

$82.08

0.147 (0.18%)

11:13
05/22/17
05/22
11:13
05/22/17
11:13
Hot Stocks
Exxon Mobil completes polyethylene lines at Texas plant »

ExxonMobil Chemical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

XOP

SPDR Oil Exploration and Production Fund

$35.37

-0.15 (-0.42%)

11:10
05/22/17
05/22
11:10
05/22/17
11:10
Options
Upside call buying in SPDR Oil Exploration and Production ETF »

Upside call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:10
05/22/17
05/22
11:10
05/22/17
11:10
General news
Treasury announced a $55 B 4-week bill auction for Tuesday »

Treasury announced a $55…

ORBK

Orbotech

$36.72

0.35 (0.96%)

11:09
05/22/17
05/22
11:09
05/22/17
11:09
Hot Stocks
Orbotech sinks after disclosing criminal probe by Israel Tax Authority »

Orbotech earlier today…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 24

    May

AVY

Avery Dennison

$83.18

0.42 (0.51%)

11:09
05/22/17
05/22
11:09
05/22/17
11:09
Hot Stocks
Avery Dennison acquires Finesse Medical »

Avery Dennison…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORBK

Orbotech

$36.72

0.35 (0.96%)

11:08
05/22/17
05/22
11:08
05/22/17
11:08
Downgrade
Orbotech rating change  »

Orbotech downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 24

    May

RPT

Ramco-Gershenson

$12.75

-0.16 (-1.24%)

11:08
05/22/17
05/22
11:08
05/22/17
11:08
Conference/Events
Ramco-Gershenson management to meet with Jefferies »

Meeting to be held in Las…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

AVT

Avnet

$36.98

-0.1099 (-0.30%)

11:06
05/22/17
05/22
11:06
05/22/17
11:06
Hot Stocks
Avnet named exclusive global distributor for Silego Technology »

Avnet and Silego…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:05
05/22/17
05/22
11:05
05/22/17
11:05
General news
4-Week Bill Announcement Offering Amount data reported »

4-Week Bill Announcement…

RARX

RA Pharmaceuticals

$24.62

-0.32 (-1.28%)

11:04
05/22/17
05/22
11:04
05/22/17
11:04
Conference/Events
RA Pharmaceuticals management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 23

    May

  • 24

    May

  • 25

    May

  • 22

    Jun

BBRY

BlackBerry

$10.38

0.27 (2.67%)

11:00
05/22/17
05/22
11:00
05/22/17
11:00
Options
Blackberry calls active as the rally continues »

Blackberry calls active…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Jun

QUOT

Quotient Technology

$11.30

0.05 (0.44%)

10:58
05/22/17
05/22
10:58
05/22/17
10:58
Conference/Events
Quotient Technology management to meet with Maxim »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 24

    May

QUOT

Quotient Technology

$11.30

0.05 (0.44%)

10:57
05/22/17
05/22
10:57
05/22/17
10:57
Conference/Events
Quotient Technology management to meet with Loop »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 24

    May

RHHBY

Roche

$34.30

0.495 (1.46%)

10:57
05/22/17
05/22
10:57
05/22/17
10:57
Hot Stocks
FDA approves Roche's Actemra for giant cell arteritis »

Genentech, a member of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 06

    Jun

  • 26

    Jun

PQ

PetroQuest

$2.42

0.1285 (5.61%)

10:56
05/22/17
05/22
10:56
05/22/17
10:56
Conference/Events
PetroQuest management to meet with Roth Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 24

    May

  • 25

    May

C

Citi

$60.95

-0.15 (-0.25%)

10:53
05/22/17
05/22
10:53
05/22/17
10:53
Hot Stocks
Citi releases statement on settlement with DOJ over BUSA »

Citi issued the following…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 25

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.